The challenge of extraabdominal desmoid tumour management in patients with Gardner's syndrome: radiofrequency ablation, a promising option.

Desmoid tumours are benign, myofibroblastic stromal neoplasms common in Gardner's syndrome, which is a subtype of familial adenomatous polyposis characterized by colonic polyps, osteomas, thyroid cancer, epidermoid cysts, fibromas and sebaceous cysts. The primary treatment is surgery, followed by adjuvant radiotherapy, but the local recurrence rate is high, and wide resection can result in debilitating loss of function. We report the case of a 39-year-old man with Gardner's syndrome who had already undergone a total prophylactic colectomy. He developed desmoid tumours localized in the mesenteric root, abdominal wall and dorsal region, which were treated from 2003 through 2013 with several surgical procedures and percutaneous radiofrequency ablation. In 2008 and 2013, RFA was applied under ultrasonographic guidance to two desmoid tumours localized in the dorsal thoracic wall. The outcomes were low-grade pain and one case of superficial skin necrosis, but so far there has been no recurrence of desmoid tumours in these locations. Surgical resection remains the first-line therapy for patients with desmoid tumours, but wide resection may lead to a poor quality of life. Radiofrequency ablation is less invasive and expensive and is a possible therapeutic option for desmoid tumours in patients with Gardner's syndrome.
AuthorsLorenzo Cobianchi, Valentina Ravetta, Francesca Torello Viera, Claudia Filisetti, Barbara Siri, Edoardo Segalini, Marcello Maestri, Tommaso Dominioni, Mario Alessiani, Sandro Rossi, Paolo Dionigi
JournalWorld journal of surgical oncology (World J Surg Oncol) Vol. 12 Pg. 361 ( 2014) ISSN: 1477-7819 [Electronic] England
PMID25429890 (Publication Type: Case Reports, Journal Article)
  • Adult
  • Catheter Ablation (methods)
  • Disease Management
  • Fibromatosis, Aggressive (etiology, pathology, surgery)
  • Gardner Syndrome (complications, pathology, surgery)
  • Humans
  • Male
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: